Godavari Drugs Ltd

Godavari Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Godavari Drugs Ltd

₹ 106 -0.14%
17 Jan - close price
godavaridrugs.com BSE: 530317
About

Incorporated in 1987, Godavari Drugs Ltd manufactures and sale of Active Pharmaceutical Ingredients and their intermediates[1]

Key Points

Business Overview:[1]
Company is in the business of Manufacturing APIs, drug intermediaries, and fine chemicals and caters to the global Life Science Industry. It has an active Loan License and Contract Manufacturing tie-ups with multinational companies for APIs and drug intermediates

Website BSE
  • Market Cap ₹ 80.0 Cr.
  • Current Price ₹ 106
  • High / Low ₹ 155 / 87.0
  • Stock P/E 12.0
  • Book Value ₹ 55.4
  • Dividend Yield 0.00 %
  • ROCE 14.4 %
  • ROE 15.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -0.53%
  • Working capital days have increased from 79.0 days to 113 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
38.67 33.76 44.28 42.55 40.55 39.16 37.37 35.42 39.54 43.11 38.64 32.21 26.09
35.76 31.17 41.58 40.15 37.98 36.89 34.69 33.17 36.47 39.59 34.17 28.98 23.19
Operating Profit 2.91 2.59 2.70 2.40 2.57 2.27 2.68 2.25 3.07 3.52 4.47 3.23 2.90
OPM % 7.53% 7.67% 6.10% 5.64% 6.34% 5.80% 7.17% 6.35% 7.76% 8.17% 11.57% 10.03% 11.12%
0.09 0.05 0.12 0.07 0.13 0.30 0.39 0.45 0.00 -0.01 0.08 0.77 0.01
Interest 0.79 0.73 0.62 0.74 1.06 1.10 1.03 1.11 1.30 1.27 1.23 1.44 1.08
Depreciation 0.43 0.43 0.42 0.46 0.47 0.51 0.50 0.47 0.49 0.50 0.53 0.55 0.58
Profit before tax 1.78 1.48 1.78 1.27 1.17 0.96 1.54 1.12 1.28 1.74 2.79 2.01 1.25
Tax % 31.46% 9.46% 29.21% 26.77% 26.50% 30.21% 13.64% 27.68% 32.81% 29.89% 4.66% 18.91% 12.80%
1.22 1.33 1.27 0.92 0.86 0.67 1.33 0.81 0.86 1.22 2.66 1.63 1.09
EPS in Rs 1.62 1.77 1.69 1.22 1.14 0.89 1.77 1.08 1.14 1.62 3.53 2.16 1.45
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
8 9 55 71 76 64 84 96 123 161 160 157 140
6 8 49 67 70 60 78 90 113 150 150 143 126
Operating Profit 2 2 6 4 5 4 5 6 10 11 10 13 14
OPM % 21% 20% 11% 6% 7% 6% 7% 6% 8% 7% 6% 8% 10%
0 0 0 0 1 1 0 0 0 0 1 1 1
Interest 0 0 1 2 3 2 3 3 3 3 4 5 5
Depreciation 1 1 1 1 1 1 1 1 1 2 2 2 2
Profit before tax 1 1 5 2 3 1 2 2 6 7 5 7 8
Tax % 33% -121% 23% 38% 33% 37% 31% 13% 28% 25% 23% 20%
0 2 4 1 2 1 1 2 4 5 4 6 7
EPS in Rs 0.64 2.06 4.85 1.79 2.40 1.10 1.61 2.66 5.48 6.97 5.03 7.37 8.76
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 32%
5 Years: 13%
3 Years: 9%
TTM: -8%
Compounded Profit Growth
10 Years: 14%
5 Years: 36%
3 Years: 11%
TTM: 92%
Stock Price CAGR
10 Years: 4%
5 Years: 47%
3 Years: 17%
1 Year: 4%
Return on Equity
10 Years: 14%
5 Years: 15%
3 Years: 15%
Last Year: 16%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 8 8 8 8 8 8 8 8 8 8 8 8 8
Reserves 0 2 6 7 9 10 11 13 17 22 26 31 34
2 2 8 16 16 19 22 28 30 23 36 58 59
5 3 13 21 24 27 33 36 36 49 52 38 27
Total Liabilities 15 15 35 51 56 63 74 84 91 101 121 135 127
7 8 7 9 13 15 15 14 22 26 25 27 34
CWIP 0 0 0 1 0 1 2 9 1 0 9 18 18
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
7 7 27 41 43 47 57 61 68 75 87 90 75
Total Assets 15 15 35 51 56 63 74 84 91 101 121 135 127

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 2 -6 -5 5 4 4 6 1 11 13 18
-1 -2 -0 -2 -3 -3 -2 -7 -1 -5 -9 -13
1 0 6 7 -2 -0 -1 0 0 -6 -4 -6
Net Cash Flow 0 -0 0 0 0 1 -0 -0 0 1 1 -0

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 32 20 87 126 117 152 148 137 134 126 132 138
Inventory Days 1,484 973 84 67 70 100 93 84 55 28 57 62
Days Payable 284 179 79 108 124 171 171 144 112 121 132 96
Cash Conversion Cycle 1,231 814 92 85 63 81 70 78 78 33 58 105
Working Capital Days 147 120 95 104 95 112 95 88 86 52 73 113
ROCE % 9% 8% 32% 16% 17% 11% 12% 12% 18% 18% 14% 14%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
56.13% 56.36% 56.92% 56.92% 53.12% 53.12% 53.16% 53.16% 53.16% 53.16% 53.16% 52.63%
0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50%
43.38% 43.15% 42.58% 42.58% 46.37% 46.39% 46.34% 46.33% 46.35% 46.34% 46.34% 46.87%
No. of Shareholders 5,7506,0346,2325,9686,6516,5556,5617,0196,8947,0057,0447,709

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings